Technology roadmap for flexible sensors

Y Luo, MR Abidian, JH Ahn, D Akinwande… - ACS …, 2023 - ACS Publications
Humans rely increasingly on sensors to address grand challenges and to improve quality of
life in the era of digitalization and big data. For ubiquitous sensing, flexible sensors are …

Type 2 diabetes

E Ahmad, S Lim, R Lamptey, DR Webb, MJ Davies - The Lancet, 2022 - thelancet.com
Type 2 diabetes accounts for nearly 90% of the approximately 537 million cases of diabetes
worldwide. The number affected is increasing rapidly with alarming trends in children and …

[HTML][HTML] Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of …

KL Ong, LK Stafford, SA McLaughlin, EJ Boyko… - The Lancet, 2023 - thelancet.com
Background Diabetes is one of the leading causes of death and disability worldwide, and
affects people regardless of country, age group, or sex. Using the most recent evidentiary …

IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021

K Ogurtsova, L Guariguata, NC Barengo… - Diabetes research and …, 2022 - Elsevier
Aims To provide up-to-date estimates of undiagnosed diabetes mellitus (UDM) prevalence-
both globally, and by region/country, for the year 2021. Methods Data sources reporting …

Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives

JS Bhatti, A Sehrawat, J Mishra, IS Sidhu… - Free Radical Biology …, 2022 - Elsevier
Abstract Type 2 diabetes (T2DM) is a persistent metabolic disorder rising rapidly worldwide.
It is characterized by pancreatic insulin resistance and β-cell dysfunction. Hyperglycemia …

2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular …

N Marx, M Federici, K Schütt… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

[HTML][HTML] Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine

DK Tobias, J Merino, A Ahmad, C Aiken, JL Benham… - Nature medicine, 2023 - nature.com
Precision medicine is part of the logical evolution of contemporary evidence-based medicine
that seeks to reduce errors and optimize outcomes when making medical decisions and …

[HTML][HTML] Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17)

RM Anjana, R Unnikrishnan, M Deepa… - The Lancet Diabetes & …, 2023 - thelancet.com
Background Non-communicable disease (NCD) rates are rapidly increasing in India with
wide regional variations. We aimed to quantify the prevalence of metabolic NCDs in India …

Global prevalence of prediabetes

MR Rooney, M Fang, K Ogurtsova, B Ozkan… - Diabetes …, 2023 - Am Diabetes Assoc
OBJECTIVE To estimate the global, regional, and national prevalence of prediabetes,
defined by impaired glucose tolerance (IGT) or impaired fasting glucose (IFG). RESEARCH …

[HTML][HTML] Optimized glycemic control of type 2 diabetes with reinforcement learning: a proof-of-concept trial

G Wang, X Liu, Z Ying, G Yang, Z Chen, Z Liu… - Nature Medicine, 2023 - nature.com
The personalized titration and optimization of insulin regimens for treatment of type 2
diabetes (T2D) are resource-demanding healthcare tasks. Here we propose a model-based …